FGF21 and inborn mitochondrial metabolism disorder: These results support the role of FGF-21 as a key regulator of metabolism in humans, and suggest that serum FGF-21 levels are associated with mitochondrial diseases and can be potentially used as a biomarker for primary MIDs.